glp-1 bulimia Medications and Eating Disorders: Risks, Benefits & Mental Health Support #504: Adult Eating Disorders in
Description
GIP supplementation was also shown to be ineffective in the 1990s when intravenous (IV) GIP was introduced to hyperglycemic patients with no effect on their blood glucose though physiologic rather than pharmacologic concentrations were supplied [20]
However, with few clinical trials, it requires consistent, long-term use to achieve and sustain results
10.1007/s00125-008-1195-5 47
Keep a log
In addition, the results also showed that from the following short-acting GLP-1 receptor agonists, liraglutide, lixisenatide, and semaglutide (Rybelsus), no conclusive acne side effects were reported
Only a few studies have evaluated the association between GLP-1RAs and ED
